Prevalence of metabolic syndrome among ethnic groups in China

Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1·3 billion. We set out to determine the prevalence of MetS and its components in different ethnic groups. This nationwide cross-sectional survey involved 24,796 participants from eight ethnicities in six provinces...

Full description

Saved in:
Bibliographic Details
Published inBMC public health Vol. 20; no. 1; pp. 297 - 8
Main Authors Qin, Xuzhen, Qiu, Ling, Tang, Guodong, Tsoi, Man-Fung, Xu, Tao, Zhang, Lin, Qi, Zhihong, Zhu, Guangjin, Cheung, Bernard M. Y.
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 06.03.2020
BioMed Central
BMC
Subjects
Abdomen
Age
Blood pressure
Cardiovascular disease
China
Cholesterol
Demographic aspects
Diabetes
Ethnic group
Ethnic groups
Ethnicity
Exercise
Gender
Health aspects
Laboratories
Metabolic disorders
Metabolic syndrome
Metabolic syndrome X
Minority & ethnic groups
Physical fitness
Physiology
Population
Prevalence studies (Epidemiology)
Provinces
Quality control
Questionnaires
Risk factors
Studies
Triglycerides
China
United States > US
Japan
Metabolic syndrome
China
Ethnic group
Online AccessGet full text
ISSN1471-2458
1471-2458
DOI10.1186/s12889-020-8393-6

Cover

Abstract Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1·3 billion. We set out to determine the prevalence of MetS and its components in different ethnic groups. This nationwide cross-sectional survey involved 24,796 participants from eight ethnicities in six provinces in China from 2008 to 2011. MetS was defined using the modified National Cholesterol Education Program Adult Treatment Panel III criteria. Results were analysed using SPSS version 22·0 in 2018. Logistic regression was used for deriving odds ratios and 95% confidence intervals of risk factors for the MetS. The prevalence of MetS increased with age from 3·60% to 21·68%. After age standardization, the prevalence of MetS, in descending order, was 35·42% (Korean), 22·82% (Hui), 19·80% (Han), 13·72% (Miao), 12·90% (Tujia), 12·04% (Li), 11·61% (Mongolian), 6·17% (Tibetan). Korean ethnicity was associated with a higher prevalence in five components of MetS, while Tibetan ethnicity was associated with lower prevalence except decreased HDL cholesterol. Logistic regression analyses showed that age, drinking and being non-Tibetan were associated with a higher risk of MetS. Within one country, albeit a large one, the prevalence of MetS can vary greatly. Chinese of Korean ethnicity had a much higher prevalence than Tibetan ethnicity. Measures to tackle MetS should be tailored to the ethnic groups within a population.
AbstractList Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1·3 billion. We set out to determine the prevalence of MetS and its components in different ethnic groups.BACKGROUNDMetabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1·3 billion. We set out to determine the prevalence of MetS and its components in different ethnic groups.This nationwide cross-sectional survey involved 24,796 participants from eight ethnicities in six provinces in China from 2008 to 2011. MetS was defined using the modified National Cholesterol Education Program Adult Treatment Panel III criteria. Results were analysed using SPSS version 22·0 in 2018. Logistic regression was used for deriving odds ratios and 95% confidence intervals of risk factors for the MetS.METHODSThis nationwide cross-sectional survey involved 24,796 participants from eight ethnicities in six provinces in China from 2008 to 2011. MetS was defined using the modified National Cholesterol Education Program Adult Treatment Panel III criteria. Results were analysed using SPSS version 22·0 in 2018. Logistic regression was used for deriving odds ratios and 95% confidence intervals of risk factors for the MetS.The prevalence of MetS increased with age from 3·60% to 21·68%. After age standardization, the prevalence of MetS, in descending order, was 35·42% (Korean), 22·82% (Hui), 19·80% (Han), 13·72% (Miao), 12·90% (Tujia), 12·04% (Li), 11·61% (Mongolian), 6·17% (Tibetan). Korean ethnicity was associated with a higher prevalence in five components of MetS, while Tibetan ethnicity was associated with lower prevalence except decreased HDL cholesterol. Logistic regression analyses showed that age, drinking and being non-Tibetan were associated with a higher risk of MetS.RESULTSThe prevalence of MetS increased with age from 3·60% to 21·68%. After age standardization, the prevalence of MetS, in descending order, was 35·42% (Korean), 22·82% (Hui), 19·80% (Han), 13·72% (Miao), 12·90% (Tujia), 12·04% (Li), 11·61% (Mongolian), 6·17% (Tibetan). Korean ethnicity was associated with a higher prevalence in five components of MetS, while Tibetan ethnicity was associated with lower prevalence except decreased HDL cholesterol. Logistic regression analyses showed that age, drinking and being non-Tibetan were associated with a higher risk of MetS.Within one country, albeit a large one, the prevalence of MetS can vary greatly. Chinese of Korean ethnicity had a much higher prevalence than Tibetan ethnicity. Measures to tackle MetS should be tailored to the ethnic groups within a population.CONCLUSIONSWithin one country, albeit a large one, the prevalence of MetS can vary greatly. Chinese of Korean ethnicity had a much higher prevalence than Tibetan ethnicity. Measures to tackle MetS should be tailored to the ethnic groups within a population.
Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1*3 billion. We set out to determine the prevalence of MetS and its components in different ethnic groups. This nationwide cross-sectional survey involved 24,796 participants from eight ethnicities in six provinces in China from 2008 to 2011. MetS was defined using the modified National Cholesterol Education Program Adult Treatment Panel III criteria. Results were analysed using SPSS version 22*0 in 2018. Logistic regression was used for deriving odds ratios and 95% confidence intervals of risk factors for the MetS. The prevalence of MetS increased with age from 3*60% to 21*68%. After age standardization, the prevalence of MetS, in descending order, was 35*42% (Korean), 22*82% (Hui), 19*80% (Han), 13*72% (Miao), 12*90% (Tujia), 12*04% (Li), 11*61% (Mongolian), 6*17% (Tibetan). Korean ethnicity was associated with a higher prevalence in five components of MetS, while Tibetan ethnicity was associated with lower prevalence except decreased HDL cholesterol. Logistic regression analyses showed that age, drinking and being non-Tibetan were associated with a higher risk of MetS. Within one country, albeit a large one, the prevalence of MetS can vary greatly. Chinese of Korean ethnicity had a much higher prevalence than Tibetan ethnicity. Measures to tackle MetS should be tailored to the ethnic groups within a population.
Background Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1·3 billion. We set out to determine the prevalence of MetS and its components in different ethnic groups. Methods This nationwide cross-sectional survey involved 24,796 participants from eight ethnicities in six provinces in China from 2008 to 2011. MetS was defined using the modified National Cholesterol Education Program Adult Treatment Panel III criteria. Results were analysed using SPSS version 22·0 in 2018. Logistic regression was used for deriving odds ratios and 95% confidence intervals of risk factors for the MetS. Results The prevalence of MetS increased with age from 3·60% to 21·68%. After age standardization, the prevalence of MetS, in descending order, was 35·42% (Korean), 22·82% (Hui), 19·80% (Han), 13·72% (Miao), 12·90% (Tujia), 12·04% (Li), 11·61% (Mongolian), 6·17% (Tibetan). Korean ethnicity was associated with a higher prevalence in five components of MetS, while Tibetan ethnicity was associated with lower prevalence except decreased HDL cholesterol. Logistic regression analyses showed that age, drinking and being non-Tibetan were associated with a higher risk of MetS. Conclusions Within one country, albeit a large one, the prevalence of MetS can vary greatly. Chinese of Korean ethnicity had a much higher prevalence than Tibetan ethnicity. Measures to tackle MetS should be tailored to the ethnic groups within a population.
Background Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1*3 billion. We set out to determine the prevalence of MetS and its components in different ethnic groups. Methods This nationwide cross-sectional survey involved 24,796 participants from eight ethnicities in six provinces in China from 2008 to 2011. MetS was defined using the modified National Cholesterol Education Program Adult Treatment Panel III criteria. Results were analysed using SPSS version 22*0 in 2018. Logistic regression was used for deriving odds ratios and 95% confidence intervals of risk factors for the MetS. Results The prevalence of MetS increased with age from 3*60% to 21*68%. After age standardization, the prevalence of MetS, in descending order, was 35*42% (Korean), 22*82% (Hui), 19*80% (Han), 13*72% (Miao), 12*90% (Tujia), 12*04% (Li), 11*61% (Mongolian), 6*17% (Tibetan). Korean ethnicity was associated with a higher prevalence in five components of MetS, while Tibetan ethnicity was associated with lower prevalence except decreased HDL cholesterol. Logistic regression analyses showed that age, drinking and being non-Tibetan were associated with a higher risk of MetS. Conclusions Within one country, albeit a large one, the prevalence of MetS can vary greatly. Chinese of Korean ethnicity had a much higher prevalence than Tibetan ethnicity. Measures to tackle MetS should be tailored to the ethnic groups within a population. Keywords: Metabolic syndrome, Ethnic group, China
Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1·3 billion. We set out to determine the prevalence of MetS and its components in different ethnic groups. This nationwide cross-sectional survey involved 24,796 participants from eight ethnicities in six provinces in China from 2008 to 2011. MetS was defined using the modified National Cholesterol Education Program Adult Treatment Panel III criteria. Results were analysed using SPSS version 22·0 in 2018. Logistic regression was used for deriving odds ratios and 95% confidence intervals of risk factors for the MetS. The prevalence of MetS increased with age from 3·60% to 21·68%. After age standardization, the prevalence of MetS, in descending order, was 35·42% (Korean), 22·82% (Hui), 19·80% (Han), 13·72% (Miao), 12·90% (Tujia), 12·04% (Li), 11·61% (Mongolian), 6·17% (Tibetan). Korean ethnicity was associated with a higher prevalence in five components of MetS, while Tibetan ethnicity was associated with lower prevalence except decreased HDL cholesterol. Logistic regression analyses showed that age, drinking and being non-Tibetan were associated with a higher risk of MetS. Within one country, albeit a large one, the prevalence of MetS can vary greatly. Chinese of Korean ethnicity had a much higher prevalence than Tibetan ethnicity. Measures to tackle MetS should be tailored to the ethnic groups within a population.
Abstract Background Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1·3 billion. We set out to determine the prevalence of MetS and its components in different ethnic groups. Methods This nationwide cross-sectional survey involved 24,796 participants from eight ethnicities in six provinces in China from 2008 to 2011. MetS was defined using the modified National Cholesterol Education Program Adult Treatment Panel III criteria. Results were analysed using SPSS version 22·0 in 2018. Logistic regression was used for deriving odds ratios and 95% confidence intervals of risk factors for the MetS. Results The prevalence of MetS increased with age from 3·60% to 21·68%. After age standardization, the prevalence of MetS, in descending order, was 35·42% (Korean), 22·82% (Hui), 19·80% (Han), 13·72% (Miao), 12·90% (Tujia), 12·04% (Li), 11·61% (Mongolian), 6·17% (Tibetan). Korean ethnicity was associated with a higher prevalence in five components of MetS, while Tibetan ethnicity was associated with lower prevalence except decreased HDL cholesterol. Logistic regression analyses showed that age, drinking and being non-Tibetan were associated with a higher risk of MetS. Conclusions Within one country, albeit a large one, the prevalence of MetS can vary greatly. Chinese of Korean ethnicity had a much higher prevalence than Tibetan ethnicity. Measures to tackle MetS should be tailored to the ethnic groups within a population.
ArticleNumber 297
Audience Academic
Author Qiu, Ling
Zhu, Guangjin
Tsoi, Man-Fung
Xu, Tao
Cheung, Bernard M. Y.
Qi, Zhihong
Zhang, Lin
Qin, Xuzhen
Tang, Guodong
Author_xml – sequence: 1
  givenname: Xuzhen
  surname: Qin
  fullname: Qin, Xuzhen
– sequence: 2
  givenname: Ling
  surname: Qiu
  fullname: Qiu, Ling
– sequence: 3
  givenname: Guodong
  surname: Tang
  fullname: Tang, Guodong
– sequence: 4
  givenname: Man-Fung
  surname: Tsoi
  fullname: Tsoi, Man-Fung
– sequence: 5
  givenname: Tao
  surname: Xu
  fullname: Xu, Tao
– sequence: 6
  givenname: Lin
  surname: Zhang
  fullname: Zhang, Lin
– sequence: 7
  givenname: Zhihong
  surname: Qi
  fullname: Qi, Zhihong
– sequence: 8
  givenname: Guangjin
  surname: Zhu
  fullname: Zhu, Guangjin
– sequence: 9
  givenname: Bernard M. Y.
  orcidid: 0000-0001-9106-7363
  surname: Cheung
  fullname: Cheung, Bernard M. Y.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32143667$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1r3DAQhkVJaT7aH9BLMfTSi1N92JJ9aCEsSRoIJIf2LGRp5NViS1vJDuTfV84mTTa06CAxeufRjOY9Rgc-eEDoI8GnhDT8ayK0adoSU1w2rGUlf4OOSCVISau6OXhxPkTHKW0wJqKp6Tt0yCipGOfiCH27jXCnBvAaimCLESbVhcHpIt17E8MIhRqD7wuY1j5H-xjmbSqcL1Zr59V79NaqIcGHx_0E_bo4_7n6UV7fXF6tzq5LXXM8ldZ2misFxGqNDbWqA8BgKyCUKtpYRjtKBTe1zVFraq1wXbHWakZqzolgJ-hqxzVBbeQ2ulHFexmUkw-BEHup4uT0AFIYY0ljqa4xq1gHilqmsBWUtUZQ0Jn1fcfazt0IRoOfohr2oPs33q1lH-6kwHwpKwO-PAJi-D1DmuTokoZhUB7CnCRlomKEt7TO0s-vpJswR5-_alG1pMoa_qzq8yCk8zbkd_UClWe5e9KI6oF1-g9VXgZGp7MxrMvxvYRPLxv92-HT8LNA7AQ6hpQiWKndpCYXlr7dIAmWi83kzmYy20wuNpNLxeRV5hP8_zl_AAMj04A
CitedBy_id crossref_primary_10_1186_s12882_025_04013_6
crossref_primary_10_1038_s41598_021_81653_2
crossref_primary_10_2147_IJGM_S319605
crossref_primary_10_1016_j_urolonc_2023_01_023
crossref_primary_10_1186_s12944_024_02354_z
crossref_primary_10_1097_MD_0000000000031320
crossref_primary_10_3390_metabo15030184
crossref_primary_10_3389_fcvm_2022_947395
crossref_primary_10_3390_nu14030456
crossref_primary_10_3390_nu15092226
crossref_primary_10_1007_s40200_023_01213_5
crossref_primary_10_1186_s12889_022_12617_y
crossref_primary_10_1007_s44211_023_00303_x
crossref_primary_10_3390_nu15092118
crossref_primary_10_3389_fendo_2023_1290855
crossref_primary_10_1007_s00406_023_01588_9
crossref_primary_10_3389_fnut_2022_888317
crossref_primary_10_1007_s44211_022_00113_7
crossref_primary_10_1186_s12889_022_13047_6
crossref_primary_10_1155_2021_8862456
crossref_primary_10_2147_DMSO_S450783
crossref_primary_10_3390_nu14112301
Cites_doi 10.1016/S0140-6736(05)66375-1
10.1016/S0140-6736(09)60145-8
10.1371/journal.pone.0151141
10.5551/jat.20529
10.1111/j.1524-6175.2006.05414.x
10.1097/gme.0b013e3182273035
10.1097/MD.0000000000002712
10.1161/HYPERTENSIONAHA.107.105205
10.3892/mmr.2012.761
10.1016/S0140-6736(05)67402-8
10.2188/jea.JE20130112
10.2174/187152907780830914
10.1093/eurpub/cks041
10.24920/J1001-9294.2017.054
10.5888/pcd14.160287
10.3390/ijerph121215035
10.4103/0366-6999.201611
10.1016/j.phrs.2017.03.008
10.1016/j.orcp.2017.03.002
10.1038/ncpendmet0616
10.1186/1471-2458-10-551
10.1161/CIRCULATIONAHA.105.169404
10.1186/s12889-017-4952-x
10.1186/s12889-016-2870-y
10.1186/s12889-016-3936-6
10.1016/j.ijcard.2013.07.034
10.1507/endocrj.EJ16-0056
10.1530/EJE-15-0275
10.2337/dc06-1820
10.1111/j.1365-2265.2007.03110.x
10.3390/ijerph14020158
10.1001/jama.285.19.2486
10.1038/ajh.2007.19
ContentType Journal Article
Copyright COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2020
Copyright_xml – notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2020
DBID AAYXX
CITATION
NPM
3V.
7T2
7X7
7XB
88E
8C1
8FE
8FG
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
AN0
ATCPS
AZQEC
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
L6V
M0S
M1P
M7S
PATMY
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PTHSS
PYCSY
7X8
5PM
DOA
DOI 10.1186/s12889-020-8393-6
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health and Safety Science Abstracts (Full archive)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
British Nursing Database (Proquest)
Agricultural & Environmental Science Collection
ProQuest Central Essentials
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
ProQuest Health & Medical Collection
Medical Database
Engineering Database
Environmental Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
Engineering Collection
Environmental Science Collection
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
ProQuest Engineering Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Agricultural & Environmental Science Collection
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Engineering Database
ProQuest Public Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Environmental Science Collection
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
Environmental Science Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Publicly Available Content Database

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1471-2458
EndPage 8
ExternalDocumentID oai_doaj_org_article_7ddf18f2c50343bea2f3a0f7239d72ec
PMC7060543
A617187425
32143667
10_1186_s12889_020_8393_6
Genre Journal Article
GeographicLocations China
United States--US
Japan
GeographicLocations_xml – name: China
– name: United States--US
– name: Japan
GrantInformation_xml – fundername: Key Technologies Research and Development Program
  grantid: 2006FY110300
– fundername: ;
  grantid: 2006FY110300
GroupedDBID ---
0R~
23N
2WC
2XV
44B
53G
5VS
6J9
6PF
7X7
7XC
88E
8C1
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABJCF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AN0
AOIJS
ATCPS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BGLVJ
BHPHI
BMC
BNQBC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
L6V
M1P
M48
M7S
M~E
O5R
O5S
OK1
OVT
P2P
PATMY
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PYCSY
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
-A0
3V.
ACRMQ
ADINQ
C24
NPM
PMFND
7T2
7XB
8FK
AZQEC
C1K
DWQXO
GNUQQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c560t-ffbc6aae1fcc0d2fabee0ef4e122a28f32b2276d5f0effd5ca05439fc31566173
IEDL.DBID M48
ISSN 1471-2458
IngestDate Wed Aug 27 01:22:19 EDT 2025
Thu Aug 21 18:12:57 EDT 2025
Thu Jul 10 18:30:25 EDT 2025
Fri Jul 25 19:23:00 EDT 2025
Tue Jun 17 20:32:13 EDT 2025
Tue Jun 10 20:42:22 EDT 2025
Wed Feb 19 02:30:31 EST 2025
Thu Apr 24 23:04:03 EDT 2025
Tue Jul 01 00:55:57 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Metabolic syndrome
China
Ethnic group
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c560t-ffbc6aae1fcc0d2fabee0ef4e122a28f32b2276d5f0effd5ca05439fc31566173
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-9106-7363
OpenAccessLink https://doaj.org/article/7ddf18f2c50343bea2f3a0f7239d72ec
PMID 32143667
PQID 2379142536
PQPubID 44782
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_7ddf18f2c50343bea2f3a0f7239d72ec
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7060543
proquest_miscellaneous_2374316925
proquest_journals_2379142536
gale_infotracmisc_A617187425
gale_infotracacademiconefile_A617187425
pubmed_primary_32143667
crossref_citationtrail_10_1186_s12889_020_8393_6
crossref_primary_10_1186_s12889_020_8393_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-03-06
PublicationDateYYYYMMDD 2020-03-06
PublicationDate_xml – month: 03
  year: 2020
  text: 2020-03-06
  day: 06
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC public health
PublicationTitleAlternate BMC Public Health
PublicationYear 2020
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References YZ Yan (8393_CR13) 2016; 2016
J Wu (8393_CR17) 2016; 95
Expert Panel on Detection E, Treatment of High Blood Cholesterol in A (8393_CR3) 2001; 285
BT Tran (8393_CR25) 2017; 17
G Pucci (8393_CR23) 2017; 120
X Qin (8393_CR14) 2012; 5
R Bentley-Lewis (8393_CR30) 2007; 3
BM Cheung (8393_CR8) 2008; 68
G Yang (8393_CR10) 2009; 373
JH Huang (8393_CR33) 2015; 12
M Kwasniewska (8393_CR35) 2012; 19
J He (8393_CR12) 2017; 14
H Xue (8393_CR21) 2016; 11
KL Ong (8393_CR32) 2008; 51
D Gu (8393_CR9) 2005; 365
JX Moore (8393_CR19) 2017; 14
Y Zhao (8393_CR22) 2017; 17
BM Cheung (8393_CR2) 2007; 7
SM Grundy (8393_CR15) 2005; 112
KW Lee (8393_CR29) 2016; 63
S von Haehling (8393_CR28) 2013; 168
Y He (8393_CR18) 2019; 28
MH Gui (8393_CR7) 2017; 130
BM Cheung (8393_CR4) 2006; 8
C Agyemang (8393_CR20) 2013; 23
M Yu (8393_CR34) 2014; 24
BM Cheung (8393_CR5) 2007; 30
KGMM Alberti (8393_CR1) 2005; 366
A Vryonidou (8393_CR31) 2015; 173
BM Cheung (8393_CR6) 2008; 21
R Li (8393_CR11) 2016; 16
T Xu (8393_CR16) 2017; 32
Y Zhao (8393_CR26) 2010; 10
BY Lin (8393_CR27) 2018; 12
L You (8393_CR24) 2014; 21
References_xml – volume: 365
  start-page: 1398
  issue: 9468
  year: 2005
  ident: 8393_CR9
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)66375-1
– volume: 373
  start-page: 792
  issue: 9666
  year: 2009
  ident: 8393_CR10
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)60145-8
– volume: 11
  start-page: e0151141
  issue: 3
  year: 2016
  ident: 8393_CR21
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0151141
– volume: 21
  start-page: 355
  issue: 4
  year: 2014
  ident: 8393_CR24
  publication-title: J Atheroscler Thromb
  doi: 10.5551/jat.20529
– volume: 8
  start-page: 562
  issue: 8
  year: 2006
  ident: 8393_CR4
  publication-title: J Clin Hypertens (Greenwich)
  doi: 10.1111/j.1524-6175.2006.05414.x
– volume: 19
  start-page: 194
  issue: 2
  year: 2012
  ident: 8393_CR35
  publication-title: Menopause
  doi: 10.1097/gme.0b013e3182273035
– volume: 95
  start-page: e2712
  issue: 10
  year: 2016
  ident: 8393_CR17
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000002712
– volume: 51
  start-page: 1142
  issue: 4
  year: 2008
  ident: 8393_CR32
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.107.105205
– volume: 5
  start-page: 1092
  issue: 4
  year: 2012
  ident: 8393_CR14
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2012.761
– volume: 366
  start-page: 1059
  issue: 9491
  year: 2005
  ident: 8393_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67402-8
– volume: 24
  start-page: 361
  issue: 5
  year: 2014
  ident: 8393_CR34
  publication-title: J Epidemiol
  doi: 10.2188/jea.JE20130112
– volume: 7
  start-page: 79
  issue: 2
  year: 2007
  ident: 8393_CR2
  publication-title: Cardiovasc Hematol Disord Drug Targets
  doi: 10.2174/187152907780830914
– volume: 23
  start-page: 447
  issue: 3
  year: 2013
  ident: 8393_CR20
  publication-title: Eur J Pub Health
  doi: 10.1093/eurpub/cks041
– volume: 32
  start-page: 218
  issue: 4
  year: 2017
  ident: 8393_CR16
  publication-title: Chin Med Sci J
  doi: 10.24920/J1001-9294.2017.054
– volume: 14
  start-page: 160287
  year: 2017
  ident: 8393_CR19
  publication-title: Prev Chronic Dis
  doi: 10.5888/pcd14.160287
– volume: 12
  start-page: 15967
  issue: 12
  year: 2015
  ident: 8393_CR33
  publication-title: Int J Environ Res Public Health
  doi: 10.3390/ijerph121215035
– volume: 130
  start-page: 669
  issue: 6
  year: 2017
  ident: 8393_CR7
  publication-title: Chin Med J
  doi: 10.4103/0366-6999.201611
– volume: 120
  start-page: 34
  year: 2017
  ident: 8393_CR23
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2017.03.008
– volume: 12
  start-page: 365
  issue: 4
  year: 2018
  ident: 8393_CR27
  publication-title: Obes Res Clin Pract
  doi: 10.1016/j.orcp.2017.03.002
– volume: 3
  start-page: 696
  issue: 10
  year: 2007
  ident: 8393_CR30
  publication-title: Nat Clin Pract Endocrinol Metab
  doi: 10.1038/ncpendmet0616
– volume: 2016
  start-page: 1
  year: 2016
  ident: 8393_CR13
  publication-title: Mediat Inflamm
– volume: 10
  start-page: 140
  issue: 1
  year: 2010
  ident: 8393_CR26
  publication-title: BMC Public Health
  doi: 10.1186/1471-2458-10-551
– volume: 112
  start-page: 2735
  issue: 17
  year: 2005
  ident: 8393_CR15
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.169404
– volume: 17
  start-page: 933
  issue: 1
  year: 2017
  ident: 8393_CR22
  publication-title: BMC Public Health
  doi: 10.1186/s12889-017-4952-x
– volume: 16
  start-page: 296
  issue: 1
  year: 2016
  ident: 8393_CR11
  publication-title: BMC Public Health
  doi: 10.1186/s12889-016-2870-y
– volume: 17
  start-page: 71
  issue: 1
  year: 2017
  ident: 8393_CR25
  publication-title: BMC Public Health
  doi: 10.1186/s12889-016-3936-6
– volume: 168
  start-page: 1509
  issue: 2
  year: 2013
  ident: 8393_CR28
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2013.07.034
– volume: 63
  start-page: 991
  issue: 11
  year: 2016
  ident: 8393_CR29
  publication-title: Endocr J
  doi: 10.1507/endocrj.EJ16-0056
– volume: 173
  start-page: R153
  issue: 5
  year: 2015
  ident: 8393_CR31
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-15-0275
– volume: 30
  start-page: 1430
  issue: 6
  year: 2007
  ident: 8393_CR5
  publication-title: Diabetes Care
  doi: 10.2337/dc06-1820
– volume: 68
  start-page: 730
  issue: 5
  year: 2008
  ident: 8393_CR8
  publication-title: Clin Endocrinol
  doi: 10.1111/j.1365-2265.2007.03110.x
– volume: 14
  start-page: 158
  issue: 2
  year: 2017
  ident: 8393_CR12
  publication-title: Int J Environ Res Public Health
  doi: 10.3390/ijerph14020158
– volume: 285
  start-page: 2486
  issue: 19
  year: 2001
  ident: 8393_CR3
  publication-title: JAMA
  doi: 10.1001/jama.285.19.2486
– volume: 21
  start-page: 17
  issue: 1
  year: 2008
  ident: 8393_CR6
  publication-title: Am J Hypertens
  doi: 10.1038/ajh.2007.19
– volume: 28
  start-page: 621
  issue: 3
  year: 2019
  ident: 8393_CR18
  publication-title: Asia Pac J Clin Nutr
SSID ssj0017852
Score 2.4186685
Snippet Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1·3 billion. We set out to determine the prevalence of MetS and its...
Background Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1*3 billion. We set out to determine the prevalence of MetS and...
Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1*3 billion. We set out to determine the prevalence of MetS and its...
Background Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1·3 billion. We set out to determine the prevalence of MetS and...
Abstract Background Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1·3 billion. We set out to determine the prevalence of...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 297
SubjectTerms Abdomen
Age
Blood pressure
Cardiovascular disease
China
Cholesterol
Demographic aspects
Diabetes
Ethnic group
Ethnic groups
Ethnicity
Exercise
Gender
Health aspects
Laboratories
Metabolic disorders
Metabolic syndrome
Metabolic syndrome X
Minority & ethnic groups
Physical fitness
Physiology
Population
Prevalence studies (Epidemiology)
Provinces
Quality control
Questionnaires
Risk factors
Studies
Triglycerides
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na90wDDejp0Ep--hHtm54UBgMQhN_JocdurFSButphd6Mv0QLW17ZS___SU7e44XBdtnVloMtS5YcSz8xdtaGDiCZtgalc61CE-rQeah10F4EoaMtwPPfrs3Vjfp6q293Sn1RTNgEDzwx7tymBG0HIupGKhmyFyB9A1bIPlmRI52-aPM2l6n5_cB2WsxvmG1nztd4ClNoEF6V0CGQtVlYoQLW_-eRvGOTlvGSOwbo8hk7mD1HfjHN-Dl7kocXbH_67canbKKX7CNBMvmSSMRXwH_mETeZCDbIBLxUF-J5vBuwteR0rPn9wEsd7UN2c_nl--ereq6QUEf0VMYaIETjfW4hxiYJ8CHnJoPKrRBedCCR3cKapAFbIeno0UOTPURJ17bWyiO2N6yGfMJ409uUgzdGgVdZpi7KlKxM0XpllYKKNRuOuTjDh1MVix-uXCM64yYmO2SyIyY7U7EP2yEPE3bG34g_0TZsCQn2ujSgMLhZGNy_hKFi72kTHSknTi76OccAl0gwV-4C10xFCIWu2OmCEpUqLrs3YuBmpV47IW3fYqfEyb7bdtNIClQb8uqx0BC4QE-fOJ6kZrskqgkljbEVswt5Wqx52TPc3xXIb8I4wp179T-Y9Jo9FaQJpYzkKdsbfz3mN-hZjeFtUaLfUk4hmA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Public Health Database
  dbid: 8C1
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3ta9cwEA46vwgivts5JYIgCGXNS5P2g8gcjiHoJwf7FvJ2bjDbuV_3_y-X5ldXhH1NrqW53F0u6eV5CPnAXAcQFKtBtrGWrnG16yzUrWstd7z1OgPP__ipjk_k99P2tBy4bUpZ5TYm5kAdRo9n5Ptc6J4lAxPqy-XfGlmj8O9qodC4Tx6wFIMRO787XEo8kHielz-ZrFP7mxSLsUAobZhSWiBqtVqLMmT__4H51sq0rpq8tQwdPSGPS_5ID-YJf0ruxeEZeTQfvtH5TtFz8hmBmWy-TkRHoH_ilKYaBbb4BDRzDNE4nQ2pNd_s2NDzgWY27Rfk5Ojbr8PjuvAk1D7lK1MN4LyyNjLwvgkcrIuxiSAj49zyDkRSOtcqtJBaIbTepjxN9OAFbt6YFi_JzjAO8TWhTa9DdFYpCVZGETovQtAieG2llhIq0mw1ZnwBEUcuiwuTNxOdMrOSTVKyQSUbVZFPyyOXM4LGXcJfcRoWQQS_zg3j1W9TfMnoEIB1wH3bCClctByEbUBz0QfNo6_IR5xEgy6aPs7bctMgDRHBrsxBGjNSEfK2InsryeRaft29NQNTXHtj_hliRd4v3fgklqsNcbzOMggx0OMrXs1WswwJmaGEUroiemVPqzGve4bzswz8jUhHaeZ27_6sN-QhRxvPNJF7ZGe6uo5vU-Y0uXfZPW4ADc4YDQ
  priority: 102
  providerName: ProQuest
Title Prevalence of metabolic syndrome among ethnic groups in China
URI https://www.ncbi.nlm.nih.gov/pubmed/32143667
https://www.proquest.com/docview/2379142536
https://www.proquest.com/docview/2374316925
https://pubmed.ncbi.nlm.nih.gov/PMC7060543
https://doaj.org/article/7ddf18f2c50343bea2f3a0f7239d72ec
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEA_38SKI-G31XCoIglBtkzRpHw65PW49hDvkcGHxJeTz7uDs6m4P9L93Jm3XKx7iSx6SaelMZjJJmvx-hLwuTBWCE0UWeOkzbnKTmUqHrDSlpoaWVkbg-ZNTcTznnxblYosM9Fa9Ade3Lu2QT2q-unr388evDxDw-zHgK_F-DWMsHvyBhRCke5aJbbILiUkik8MJ__NTQVaRgKeA8TijvKz6n5y3vmKUpiKa_99j9o2kNT5QeSNDze6Te_3UMj3ofOEB2fLNQ3K325dLu-tGj8g-YjbpeNMoXYb0m2_BC1BggC5II_1Q6tuLBmrjpY91etmkkWj7MZnPjr4cHmc9hUJmYSrTZiEYK7T2RbA2dzRo433uA_cFpZpWgUF_UClcGaA2uNJqmMKxOliG67pCsidkp1k2_hlJ81o6b7QQPGjumassc04yZ6XmkvOQkHywmLI9vjjSXFypuM6ohOqMrMDICo2sRELebh753oFr_Et4it2wEURc7FixXJ2rPsyUdC4UVaC2zBlnxmsamM6DpKx2knqbkDfYiQr9CT7O6v4SAqiIOFjqAHRGlkJaJmRvJAlRZ8fNgxuowWkVZbIuoJHBx77aNOOTeJKt8cvrKIPoAzW-4mnnNRuVkDSKCSETIkf-NNJ53NJcXkRMcARBgp57_t_6vSB3KLp7JJPcIzvt6tq_hPlVayZkWy4klNVhgeXs44TsTo9OP59N4o7FJEYVlGfTr78BcqAniA
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1da9YwFD7MeaEg4rfVqRUUQShrkzRpL4bM6XjnPq422F3MpxtoO_d2iH_K32hO-uGKsLvdJqclOTk5J2nPeR6AN4WuvLe8yDwrXcZ0rjNdKZ-VulREk9KICDy_f8AXR-zLcXm8An_GWhhMqxx9YnTUtjX4jXydUFEXwcAo_3D2M0PWKPy7OlJo9Gax637_Cle25cbOp7C-bwnZ_ny4tcgGVoHMhOjeZd5rw5VyhTcmt8Qr7VzuPHMFIYpUnoYhEsFt6UOrt6VR4VRDa28oXnUKQcN7b8BNRqlArP5qa0opQaJ7Mvw5LSq-vgy-HxOSwgUtHENoxmexL1IE_B8ILkXCeZbmpbC3fQ_uDufVdLM3sPuw4poHcKf_2Jf2NUwPYQOBoFQsX0pbn_5wXTAtFBjxENLIaZS67qQJrbGSZJmeNmlk734ER9eiwcew2rSNewppXgvrtOKcecUctZWh1gpqjVBMMOYTyEeNSTOAliN3xncZLy8Vl72SZVCyRCVLnsD76ZGzHrHjKuGPuAyTIIJtx4b2_Jsc9q4U1vqi8sSUOWVUO0U8VbkXhNZWEGcSeIeLKNElhMEZNVQ2hCkiuJbcDHNG6kNSJrA2kwxb2cy7RzOQgytZyn-Gn8DrqRufxPS4xrUXUQYhDWp8xZPeaqYpIRMV5VwkIGb2NJvzvKc5PYlA44isFFbu2dXDegW3Fof7e3Jv52D3OdwmaO-RonINVrvzC_cinNo6_TJulRS-Xvfe_AsQoleR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+metabolic+syndrome+among+ethnic+groups+in+China&rft.jtitle=BMC+public+health&rft.au=Qin%2C+Xuzhen&rft.au=Qiu%2C+Ling&rft.au=Tang%2C+Guodong&rft.au=Tsoi%2C+Man-Fung&rft.date=2020-03-06&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2458&rft.eissn=1471-2458&rft.volume=20&rft.issue=1&rft_id=info:doi/10.1186%2Fs12889-020-8393-6&rft.externalDocID=A617187425
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2458&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2458&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2458&client=summon